4th Antigen Specific Immune Tolerance Digital Summit

The 4th Antigen Specific Immune Tolerance Digital Summit ASIT brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building...
Medicine and Me... Medicine and M...
The 4th Antigen Specific Immune Tolerance Digital Summit ASIT brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to drive the field towards a more precise and ethical antigen-specific approach to drug development. URLs: Brochure: https:go.evvnt.com695794-0?pid1774 Tickets: https:go.evvnt.com695794-1?pid1774 Prices: Drug Developers Earlybird rates and workshops available: USD 1999.0, Academic Earlybird rates and workshops available: USD 1799.0, Solution Providers Earlybird rates and workshops available: USD 2499.0 Speakers: Charlotte Fribert, Chief Executive Officer, Toleranzia AB, Jean Van Rampelbergh, VP Clinical and Regulatory, Imcyse, Jose Carballido, Executive Director Translational Medicine Preclinical Safety, Novartis and more Time: 08:00 - 18:00
info@hansonwade.com
Online, Online, United States of America